
Integer Holdings (ITGR) Stock Forecast & Price Target
Integer Holdings (ITGR) Analyst Ratings
Bulls say
Integer Holdings Corp is demonstrating strong revenue growth, particularly in its Cardio & Vascular segment, which increased by 15% in Q3 2025, and the overall market for its products in Cardiac Rhythm Management & Neuromodulation is positioned to grow in line with broader market trends. The company expects stable gross margins and continuous revenue growth projections, estimating revenues of $1.87 billion for 2026, reflecting a 1.5% increase over 2025. Furthermore, Integer's operating cash flow is set to improve significantly, projected to reach $230-$240 million in 2025, thereby enhancing financial flexibility and reducing leverage ratios, which aligns with favorable long-term market conditions in the cardiovascular device sector.
Bears say
Integer Holdings Corp has adjusted its revenue estimates for 4Q25 to $460.0 million, a modest 2% increase from the prior year but lower than previous expectations, indicating concerns about sustained growth. The company has also revised its full-year 2025 revenue guidance downward by $16 million, alongside a flat-to-lower outlook for 2026 driven by decreased demand for crucial products, which reflects a significant slowdown compared to typical growth expectations. Additionally, the management's acknowledgment of lower sales contributions from core franchises and potential underperformance in organic growth drivers introduces a risk of further downgrades in financial forecasts.
This aggregate rating is based on analysts' research of Integer Holdings and is not a guaranteed prediction by Public.com or investment advice.
Integer Holdings (ITGR) Analyst Forecast & Price Prediction
Start investing in Integer Holdings (ITGR)
Order type
Buy in
Order amount
Est. shares
0 shares